Publications by authors named "S F B van der Horst"
Objective: To investigate the prognostic value of baseline European Association of Nuclear Medicine Research Ltd. (EARL) standardized [F]fluorodeoxyglucose positron emission tomography-computed tomography ([F]FDG PET-CT) quantitative values for survival and to evaluate cutoff values identified in other studies.
Materials And Methods: Pediatric and adolescent patients with high-grade osteosarcoma were included.
Soft tissue tumor imaging in adults: European Society of Musculoskeletal Radiology-Guidelines 2024: imaging immediately after neoadjuvant therapy in soft tissue sarcoma, soft tissue tumor surveillance, and the role of interventional radiology.
Eur Radiol
December 2024
Article Synopsis
- The ESSR updated its 2015 consensus on soft tissue tumor imaging due to advancements in technology and updated classifications.
- A panel of 46 radiologists from 12 European countries used a validated Delphi method to reach consensus on imaging strategies, resulting in high agreement on 47 statements.
- Key findings highlight that MRI is preferred for monitoring soft tissue sarcomas, with chest CT recommended for assessing metastasis and interventional radiology playing a role in treating specific cases.
Unlabelled: Understanding how mechanical stimulation from exercise influences cellular responses during tissue repair could enhance therapeutic strategies. We explored zebrafish caudal fin regeneration to study exercise impacts on a robust model of tissue regeneration. We used a swim tunnel to determine that exercise initiated during but not after blastema establishment impaired fin regeneration, including of the bony ray skeleton.
View Article and Find Full Text PDFBackground: Parameningeal (PM) site is an unfavorable characteristic in rhabdomyosarcoma (RMS). We described the treatment and outcome for patients with PM RMS and investigated the prognostic value of risk factors. We scored PM site by originating site and by highest risk extension.
View Article and Find Full Text PDFHow to Incorporate Subcutaneous Infliximab and Vedolizumab in Your Practice.
Clin Gastroenterol Hepatol
October 2024